Conventional heart failure therapy including diuretics, renin–angiotensin–aldosterone system inhibitors, ß-blockers and so on has been shown to attenuate DOX-induced cardiomyopathy and heart failure but the only viable choice for patients with serious DOX-induced cardiomyopathy and heart failure is heart transplantation [28]. This evidence concerns the gene REN and heart failure.